Sales of manometry systems totaled US$ 184.18 million in 2023. The manometry system market might increase positively at a 5.4% CAGR and reach US$ 311.64 million in value by 2033. The key drivers influencing the manometry system industry are the rising prevalence of fecal incontinence and constipation, the rising old population, technological improvements, and expanding healthcare infrastructure.
The global manometry system industry is to be driven in the forthcoming years by rising per capita healthcare spending and increased investment in the construction of healthcare infrastructure. In addition, it is predicted that low patient and physician knowledge and high costs may restrain market expansion for manometry systems in developing and emerging economies.
The hospital industry is predicted to hold a significant portion of the manometry system business due to the widespread use of manometry for numerous diagnostic procedures to monitor over an extended period. The category is projected to be supported by rising demand for short-term hospital stays and an increase in the number of gastrointestinal procedures performed at ambulatory surgical centers, such as endoscopy.
| Attributes | Details |
|---|---|
| Manometry System Market CAGR (2023 to 2033) | 5.4% |
| Manometry System Market Size - 2023 | US$ 184.18 million |
| Manometry System Market Size - 2033 | US$ 311.64 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The manometry system market experienced a considerable increase from 2018 to 2022 and was propelled by factors such as:
The manometry system industry saw an increase in demand during this time, leading companies to launch novel goods and broadening their regional reach.
The manometry system market is anticipated to maintain its growth trajectory between 2023 and 2033. The aging population, rising gastrointestinal disease awareness, and increasing healthcare costs are all anticipated to fuel market growth for manometry systems. Moreover, improvements in manometry technology, such as wireless and high-resolution devices are probably going to support market expansion for manometry systems.
Manometry systems are predicted to benefit from the use of artificial intelligence and data analytics since they may improve diagnostic precision and streamline patient care. Problems like the pricey manometry systems and the poor accessibility in some areas may impede market expansion to some extent.
The demand for precise diagnostic tools in gastroenterology, rising illness prevalence, and technological improvements are expected to drive the manometry system industry in the forthcoming years.
A breakthrough development in the manometry system industry was the introduction of a novel portable manometry instrument. Demand for portable manometry systems increased as a result of these devices' ability to offer exact results with real-time data on a tablet PC workstation.
Portable manometry equipment is an affordable way to diagnose individuals with incontinence, chronic constipation, and other conditions of the lower gastrointestinal tract. It makes it easy for urogynecologists to recognize and treat particular anorectal issues.
The Mcompass from Medspira is the first portable, user-friendly manometry tool in the world, making testing straightforward, rapid, and flexible. Such developments are anticipated to offer the manometry system business a significant prospect for growth.
Principal Consultant
Leading corporations place a strong emphasis on creating technologically sophisticated and novel products to obtain a competitive edge. The manometry system manufacturers have tremendous potential thanks to the rising demand for technologically advanced items and equipment installed base in end-use facilities.
Enhancement and simplification of regulatory procedures, as well as increased financial support for life science research in developing nations, may promote the market expansion of manometry system manufacturers’ product portfolios. Moreover, companies are concentrating on merger, collaborations, and acquisition for expansion and the demand for manometry systems have dramatically increased recently.
| Country | The United States |
|---|---|
| Attributes | Market Share |
| Details | 92.3% |
| Country | Germany |
|---|---|
| Attributes | Market Share |
| Details | 25% |
| Country | China |
|---|---|
| Attributes | Market CAGR |
| Details | 8.3% |
As per Future Market Insights, the United States is expected to dominate North America’s manometry system market, accounting for over 92.3% value share in 2023. Growth in the country is primarily driven by the factors including:
These factors are expected to drive the growth of the manometry system business in the United States.
Germany’s manometry system industry is expected to account for 25% of the total market share in 2023. As per the study, Germany is anticipated to emerge as the significant manometry system industry across Europe. This demand is primarily due to factors such as:
Demand for manometry systems in China is projected to expand at an 8.3% CAGR in East Asia throughout the forecast period. In China, the high prevalence of gastrointestinal motility diseases, the increasing elderly population, disposable incomes, favorable government policies, and funding for life science research are the factors affecting current and future manometry system industry trends.
Implementation of healthcare reforms and health awareness is a key factor driving the market growth for manometry systems in the forecast period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Product |
|---|---|
| Sub Segment | System Sheath & Catheters (Share) |
| Details | 58% |
| Segment | Product |
|---|---|
| Sub Segment | System Sheath & Catheters (CAGR) |
| Details | 4.5% |
| Segment | Portability |
|---|---|
| Sub Segment | Stand Alone System (Share) |
| Details | 57.3% |
| Segment | End-user |
|---|---|
| Sub Segment | Hospitals (Share) |
| Details | 39.7% |
In terms of product, the system sheath & catheters may hold the leading share of around 58% in 2023. Demand for sheath and catheter manometry systems is projected to rise at 4.5% CAGR during the forecast period.
As system sheaths & catheters minimize the risk of cross-contamination, reduce manual cleaning efforts, and can be removed and discarded immediately after the procedure, adoption is expected to surge over the forthcoming decade.
Based on portability, the stand-alone manometry system is expected to hold a mammoth share, capturing a market value of 57.3% in 2023. Driven by its enhanced sensitivity as it provides useful information to support the diagnosis of conditions such as dysphagia, achalasia, and hiatal hernia, adoption within hospitals and diagnostic centers has increased.
Stand-alone manometry systems also help to get the complete pressure profile of patients, which is expected to continue to boost the demand in the forthcoming years.
In terms of end-user, the hospital segment is expected to account for 39.7% of the manometry system market share in 2023. Expanding patient pool and rising demand for hospital stays that is short-term is expected to boost the segment growth.
The increasing number of gastrointestinal processes like endoscopy that are done at hospitals are likely to fuel segment growth.
Manufacturers can use the following tactics to grow their company in the manometry system market:
Product Diversification
The manometry system manufacturers ought to broaden their selection of goods by creating a variety of manometry systems for diverse medical uses. As a result, they can serve a large consumer base and gain market share.
Market Expansion
The manometry system manufacturers can reach new client segments and expand their market reach by focusing on new geographic areas and the unexplored manometry system industry. This can entail forming alliances with distributors or organizing regional sales and service teams.
Research and Development
To keep ahead of the competition, research and development must be continually funded. To adapt to changing consumer needs and tastes, manufacturers should concentrate on improving the performance, accuracy, and usefulness of their manometry devices.
Strategic Partnerships
The manometry system manufacturers can increase their reputation and market awareness by collaborating with hospitals, clinics, and key opinion leaders. These alliances may result in cooperative product development, distribution contracts, and endorsements, which may spur company expansion.
Marketing and Branding
To raise awareness and demand for manometry devices, effective marketing and branding strategies are crucial. To position their brand as a dependable and trustworthy solution provider in the market, manometry system manufacturers could use digital marketing channels, attend industry conferences, and engage in thought leadership activities.
A variety of expansion methods, including mergers and acquisitions, collaborations, and partnerships with other manometry system manufacturers, are being used by the leading competitors in the manometry system business.
The manometry system business has been impacted by several joint ventures, agreements, and loan licensing procedures. Governments in developing nations have implemented many changes to develop the market, including regulating it to increase transparency and allowing foreign investment in some sectors.
Prominent Manometry System Manufacturers
| Company | SMART Medical Systems |
|---|---|
| Strategy |
FDA Grants Additional Clearance to G-EYE® Colonoscope: Revolutionizing Lesion Detection |
| Details | The G-EYE® colonoscope from SMART Medical Systems, an Albyn Medical subsidiary, acquired additional FDA clearance in February 2021, and clinical testing has now started in the USA. The G-EYE® Colonoscope is a cutting-edge detection and treatment tool that aids doctors in locating polyps lurking beneath possible adenomas, flat lesions between or on the colonic folds, and other lesions. |
| Company | ALBYN MEDICAL SL |
|---|---|
| Strategy | Boucart Medical SRL Joins Forces with Albyn Medical SL, an Expert in Gastroenterology and Urology, in Recent Acquisition |
| Details | 2020 November. ALBYN MEDICAL SL, a Creo Medical Company with expertise in gastroenterology and urology, recently announced the acquisition of BOUCART MEDICAL SRL. a top distributor of endoscopic accessories with headquarters in Brussels, Belgium. |
| Company | OptilumeTM |
|---|---|
| Strategy | LABORIE Medical Technologies and Urotronic Forge Strategic Agreement for OptilumeTM Regulatory Approval |
| Details | To facilitate regulatory approval of OptilumeTM, a drug-coated balloon (DCB) technology for treatment in urethral strictures and benign prostatic hyperplasia (BPH), LABORIE Medical Technologies and Urotronic may enter into a strategic agreement in October 2020. |
| Company | Synergy Medical |
|---|---|
| Strategy | Synergy Medical and Parata Systems Unite to Transform Pharmacy Automation |
| Details | Synergy Medical and Parata Systems unite in October 2020 to form the industry leader in pharmacy automation. This combination may aid in business growth and provide cutting-edge pharmacy automation solutions to satisfy the demands of government, long-term care, retail, and direct-to-home pharmacies. |
| Company | Sandhill Scientific |
|---|---|
| Strategy | Sandhill Scientific and Medovations Combine under Diversatek Inc |
| Details |
Sandhill Scientific and Medovations were combined by Diversatek Inc. in April 2017 to strengthen the position of the business in the endoscopy and GI diagnostic markets. |
The market is forecasted to register a CAGR of 5.4% through 2033.
The market is estimated to reach US$ 311.64 by 2033.
The market is estimated to secure a valuation of US$ 184.18 million in 2023.
Prometheus Group, Smart Medical Group, and Synectics Medical Limited are key players in the market.
The hospital sector holds high revenue potential.
China may witness significant growth in the manometry system market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Anorectal Manometry System
5.3.2. Anorectal Software
5.3.3. Anorectal Sheath & Catheters
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Portability
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Portability, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Portability, 2023 to 2033
6.3.1. Stand Alone System
6.3.2. Portable System
6.4. Y-o-Y Growth Trend Analysis By Portability, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Portability, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Speciality Clinics
7.3.4. Academic Research Institutes
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Portability
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Portability
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Portability
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Portability
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Portability
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Portability
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Portability
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Portability
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Portability
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Portability
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Portability
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Portability
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Portability
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Portability
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Portability
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Portability
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Portability
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Portability
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Portability
16.5.2.3. By End User
16.6. U.K.
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Portability
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Portability
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Portability
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Portability
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Portability
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Portability
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Portability
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Portability
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Portability
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Portability
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Portability
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Portability
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Portability
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Portability
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Portability
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Portability
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Product
16.22.2.2. By Portability
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Product
16.23.2.2. By Portability
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Portability
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. EB Neuro S.p.A
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. MEDSPIRA
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. Medtronic
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Medica S.p.A.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. RMS Medical Devices
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. MARQUAT Génie Biomédical
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy
18.1.7. Diversatek Inc.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.7.5.2. Product Strategy
18.1.7.5.3. Channel Strategy
18.1.8. Dentsleeve International Ltd.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.8.5.2. Product Strategy
18.1.8.5.3. Channel Strategy
18.1.9. LABORIE
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.9.5.2. Product Strategy
18.1.9.5.3. Channel Strategy
18.1.10. Prometheus Group
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.10.5.2. Product Strategy
18.1.10.5.3. Channel Strategy
18.1.11. Smart Medical Group
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.11.5.2. Product Strategy
18.1.11.5.3. Channel Strategy
18.1.12. Synectics Medical Limited
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.12.5.2. Product Strategy
18.1.12.5.3. Channel Strategy
18.1.13. Medovations Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.13.5.2. Product Strategy
18.1.13.5.3. Channel Strategy
18.1.14. Sierra Scientific
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.14.5.2. Product Strategy
18.1.14.5.3. Channel Strategy
18.1.15. Urotech Gmbh
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
18.1.15.5.2. Product Strategy
18.1.15.5.3. Channel Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Manometry System Market
